Education and Training
Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing
FLIP topography has been FDA cleared to evaluate a variety of esophageal conditions, but has never been evaluated in patients with scleroderma. The investigators hope to evaluate this technology in patients who have scleroderma and various esophageal symptoms, and compare to non-scleroderma patients.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- device: FLIP topography
- procedure: Upper Endoscopy
Eligibility
Inclusion Criteria:
- Must have a clinical indication for upper endoscopy (recruiting patients both with
scleroderma and without)
Exclusion Criteria:
- not healthy enough to undergo an upper endoscopy
- mass, stricture, ring, or web present on upper endoscopy
- history of esophageal cancer
- history of esophageal surgery
Ages Eligible for Study
18 Years - 90 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
John O Clarke, MD
650-736-5555
Not Recruiting